Ziwig Endotest
Commercial- Indications
- Endometriosis
Company intelligence / Profile preview
Ziwig’s flagship product, the Endotest®, is a CE-marked in vitro diagnostic test that uses salivary miRNA profiles analyzed by NGS and AI to diagnose endometriosis. Clinical studies have shown over 95% sensitivity and specificity, validated in one of the largest clinical trials for endometriosis. The test is available in several European countries and select Middle Eastern markets. Additional pipeline projects target other women’s health conditions, gynecological cancers, and neurodegenerative diseases like ALS
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ziwig.